Stockreport

Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers [Yahoo! Finance]

Genprex, Inc.  (GNPX) 
Last genprex, inc. earnings: 11/14 12:08 pm Check Earnings Report
PDF AUSTIN, Texas Nov. 18, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX ), a clinical-stage gene therapy company focused on developing life [Read more]